3 not yet recruiting, 2 completed, 1 recruiting. 4 Phase 2, 2 Not applicable.
| Phase | Trials | Status |
|---|---|---|
| Phase 2 | 4 | Not yet recruiting 2, Completed 1, Recruiting 1 |
| Not applicable | 2 | Completed 1, Not yet recruiting 1 |
Follow Conditioning Therapy: new trials by email Literature Review of Conditioning Therapy trials Research Report on Conditioning Therapy
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| SHR2554/AZA + Overlapped Modified BUCY for High-risk/Relapsed Leukemia/MDS SHR2554/AZA + Overlapped mBUCY, mBUCY conditioning Regimen Group - Acute Myeloid Leukemia, Acute Lymphoblastic Leukemia | Phase 2 | Not yet recruiting | The First Affiliated Hospital of Soochow University | 180 | 2026-06-01 | 2026-06-10 |
| SHR2554/AZA + Overlapped TBF for High-risk/Relapsed Leukemia/MDS SHR2554/AZA + Overlapped TBF, mBUCY conditioning regimen - Acute Myeloid Leukemia, Acute Lymphoblastic Leukemia | Phase 2 | Not yet recruiting | The First Affiliated Hospital of Soochow University | 160 | 2026-06-01 | 2026-05-01 |
| REACTION-VAD Trial: Remote Exercise Training Via Telemedicine in Patients With Long-Term Ventricular Assist Devices Remote Physical Conditioning Program (Telerehabilitation), Usual care. No Remote Monitoring. - Heart Failure, Advanced Heart Failure | Not applicable | Not yet recruiting | Puerta de Hierro University Hospital | 78 | 2026-05-01 | 2026-05-28 |
| Study on the Efficacy and Safety of the TmBU Conditioning Regimen in High-risk or Relapsed/Refractory Acute Leukemia TmBU conditioning Regimen, mBUCY conditioning regimen - Acute Myeloid Leukemia, Acute Lymphoblastic Leukemia | Phase 2 | Recruiting | The First Affiliated Hospital of Soochow University | 48 | 2025-01-30 | 2026-04-23 |
| Non-invasive Remote Ischemic PreConditioning (RIPC) in Free Flaps for Breast Reconstruction Remote ischemic preconditiong - Ischemia-Reperfusion Injury, Free Flap | Not applicable | Completed | Ruhr University of Bochum | 49 | 2021-04-01 | 2026-03-25 |
| Bendamustine, Cytarabine, Etoposide and Melphalan (BeEAM) as Conditioning for Autologous Stem Cell Transplant (ASCT) in Aggressive Non Hodgkin's Lymphoma (NHL). Bendamustine-EAM - Bendamustine, Conditioning Therapy | Phase 2 | Completed | Grupo Español de Linfomas y Transplante Autólogo de Médula Ósea | 60 | 2011-05-01 | 2016-02-17 |
Leukemia, Myeloid, Acute (3) · Precursor Cell Lymphoblastic Leukemia-Lymphoma (3) · Heart Failure (1) · Ischemia (1) · Reperfusion Injury (1)
Hematologic Diseases (3) · Hemic and Lymphatic Diseases (3) · Immune System Diseases (3) · Immunoproliferative Disorders (3) · Leukemia (3) · Leukemia, Lymphoid (3) · Leukemia, Myeloid (3) · Lymphatic Diseases (3) · Lymphoproliferative Disorders (3) · Neoplasms (3) · Neoplasms by Histologic Type (3) · Cardiovascular Diseases (2) · Heart Diseases (1) · Pathologic Processes (1) · Pathological Conditions, Signs and Symptoms (1)
Control Groups (2) · Telerehabilitation (1)
The First Affiliated Hospital of Soochow University (3) · Grupo Español de Linfomas y Transplante Autólogo de Médula Ósea (1) · Puerta de Hierro University Hospital (1) · Ruhr University of Bochum (1)
China (3) · Spain (2) · Germany (1)
Carlos Grande, MD (1) · Cristina Barrenetxea, MD (1) · Cristina Castilla, MD (1) · Eulogio Conde, MD (1) · Isidro Jarque, MD (1) · Javier Briones, MD (1) · Jorge Gayoso, MD (1)